Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 8 of 8 for “"second-generation antipsychotics"”.
-
Identifying Barriers To Implementing Guidelines For Monitoring Metabolic Syndrome In Patients Prescribed Second-Generation Antipsychotics In Incarcerated Populations
… and mortality. Also, the evidence indicates that second-generation antipsychotics (SGAs, a conventional treatment) increase the risk of metabolic syndrome (MetS) often leading to weight gain, cardiovascular disease (CVD) and type 2 diabetes (DM 2). U. S. correctional institutions, faced with …
-
Identifying Barriers To Implementing Guidelines For Monitoring Metabolic Syndrome In Patients Prescribed Second-Generation Antipsychotics In Incarcerated Populations
… and mortality. Also, the evidence indicates that second-generation antipsychotics (SGAs, a conventional treatment) increase the risk of metabolic syndrome (MetS) often leading to weight gain, cardiovascular disease (CVD) and type 2 diabetes (DM 2). U. S. correctional institutions, faced with …
-
Management of Treatment-Resistant Schizophrenia
… can be subdivided into typical and atypical antipsychotics, or first and second-generation antipsychotics respectively. In the case of treatment resistance to the initial antipsychotic trial, there a several approaches to treat patients with treatment-resistant schizophrenia. Some of these …
-
A associação do ganho de peso com o uso de quetiapina ou risperidona em pacientes com esquizofrenia: uma revisão sistemática
… have improving in recent decades with the use of antipsychotics. However, one of the major side effects of these medicines is the significant weight gain. These neuroleptics are divided into two classes representing the first and second generation, being the second generation antipsychotics the …
-
Investigation of potential biomarkers of treatment-resistant schizophrenia
… treatment for people with TRS where other antipsychotics have failed. Yet its use is limited by potentially fatal side effects and there is still a subset, approximately 50- 70% of patients treated with clozapine, who do not experience clinically significant improvements in their symptoms, …
-
Framing's Influence on Maternal Acceptability of Off-Label Risperdal in Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment
… professionals have recently started prescribing second-generation antipsychotics (SGAs), like Risperdal, to ADHD youth without the U.S. Food and Drug Administration’s (FDA) approval. This off-label prescribing trend is increasingly becoming common practice despite variability in knowledge …
-
METABOLIC ADVERSE EFFECTS INDUCED BY SECOND GENERATION ANTIPSYCHOTIC DRUGS IN PEDIATRIC PATIENTS: PHARMACOGENETIC PROFILING AND MECHANISTIC ANALYSIS OF GENETIC VARIANTS EFFECT IN VITRO MODELS
Second-generation antipsychotics (SGAs) are increasingly used in pediatric patients both in and offlabel. The rise in SGA prescription rates may be due to the perception of improved safety compared with first-generation antipsychotics. However, SGA use is often associated with rapid weight gain and …
-
Safety and Effectiveness of Antidepressants in Medicaid-Enrolled Pediatric Bipolar Depression
… includingmood stabilizers, antidepressants, and antipsychotics for treating bipolar depression in adults is well established (Lin et al., 2006), similar treatment guidelines for bipolar depression in younger populations are unavailable. Efficacy of different classes of medications in treating …